315 related articles for article (PubMed ID: 36773789)
1. Advances in traditional Chinese medicine for the treatment of chronic obstructive pulmonary disease.
Cao X; Wang Y; Chen Y; Zhao M; Liang L; Yang M; Li J; Peng M; Li W; Yue Y; Zhang H; Li C; Shu Z
J Ethnopharmacol; 2023 May; 307():116229. PubMed ID: 36773789
[TBL] [Abstract][Full Text] [Related]
2. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.
Li LC; Kan LD
J Ethnopharmacol; 2017 Feb; 198():45-63. PubMed ID: 28038955
[TBL] [Abstract][Full Text] [Related]
4. Screening of traditional Chinese medicines with therapeutic potential on chronic obstructive pulmonary disease through inhibiting oxidative stress and inflammatory response.
Zhou MX; Wei X; Li AL; Wang AM; Lu LZ; Yang Y; Ren DM; Wang XN; Wen XS; Lou HX; Shen T
BMC Complement Altern Med; 2016 Sep; 16(1):360. PubMed ID: 27623767
[TBL] [Abstract][Full Text] [Related]
5. Review on the potential roles of traditional Chinese medicines in the prevention, treatment, and postoperative recovery of age-related cataract.
Liu XM; Shi H; Li W
J Ethnopharmacol; 2024 Apr; 324():117786. PubMed ID: 38253273
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional effects and mechanisms of traditional Chinese medicine.
Peng X; Tang F; Yang Y; Li T; Hu X; Li S; Wu W; He K
J Ethnopharmacol; 2022 Nov; 298():115578. PubMed ID: 35917892
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas.
Wang Y; Chen YJ; Xiang C; Jiang GW; Xu YD; Yin LM; Zhou DD; Liu YY; Yang YQ
J Ethnopharmacol; 2020 Apr; 252():112635. PubMed ID: 32004629
[TBL] [Abstract][Full Text] [Related]
8. [Clinical practice guideline for stable chronic obstructive pulmonary disease with traditional Chinese medicine (draft version for comments)].
Chang-Zheng F; Qing M; Mao-Rong F; Xing L; Qiong Z; Yi-Ling F; Qiu-Xiao MA; Qing C; Ning W; Ya-Ni H
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5309-5322. PubMed ID: 33350190
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of combined traditional Chinese and western medicine in the treatment of chronic obstructive pulmonary disease complicated with respiratory failure: a systematic review and meta-analysis study.
Huang P; Lin X; Liu Y; Hou Z
Ann Palliat Med; 2022 Mar; 11(3):1102-1111. PubMed ID: 35365040
[TBL] [Abstract][Full Text] [Related]
10. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.
Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X
Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095
[TBL] [Abstract][Full Text] [Related]
11. [Survey of study on therapeutic mechanism of chronic obstructive pulmonary disease treated by traditional Chinese medicine].
Jiang YX; Wu JF; Du J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):860-4. PubMed ID: 16248256
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression.
Li B; Xu M; Wang Y; Feng L; Xing H; Zhang K
J Ethnopharmacol; 2023 Mar; 303():116038. PubMed ID: 36529248
[TBL] [Abstract][Full Text] [Related]
13. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia.
Xie W; Zhao Y; Du L
J Ethnopharmacol; 2012 Mar; 140(2):345-67. PubMed ID: 22306102
[TBL] [Abstract][Full Text] [Related]
14. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
[TBL] [Abstract][Full Text] [Related]
15. Chinese oral herbal paste for the treatment of stable chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis.
Zeng Y; Li Y; Wei H; Xiong C; Liao L; Miao TW; Mao B; Fu JJ
Medicine (Baltimore); 2019 Jul; 98(28):e16444. PubMed ID: 31305473
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of traditional Chinese medicine on stable chronic obstructive pulmonary disease: A systematic review and meta-analysis.
Haifeng W; Hailong Z; Jiansheng L; Xueqing Y; Suyun L; Bin L; Yang X; Yunping B
Complement Ther Med; 2015 Aug; 23(4):603-11. PubMed ID: 26275654
[TBL] [Abstract][Full Text] [Related]
17. Research progress in the treatment of slow transit constipation by traditional Chinese medicine.
Wang L; Wu F; Hong Y; Shen L; Zhao L; Lin X
J Ethnopharmacol; 2022 May; 290():115075. PubMed ID: 35134487
[TBL] [Abstract][Full Text] [Related]
18. The medicinal uses of the genus Mahonia in traditional Chinese medicine: An ethnopharmacological, phytochemical and pharmacological review.
He JM; Mu Q
J Ethnopharmacol; 2015 Dec; 175():668-83. PubMed ID: 26387740
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics study on model rats of chronic obstructive pulmonary disease treated with Bu‑Fei Jian‑Pi.
Li J; Yang L; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X
Mol Med Rep; 2015 Feb; 11(2):1324-33. PubMed ID: 25370181
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of traditional Chinese medicine for interstitial lung disease.
Zhou YM; Dong XR; Xu D; Tang J; Cui YL
J Ethnopharmacol; 2024 Jan; 318(Pt A):116952. PubMed ID: 37487964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
